We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RTTR market cap is 2.32M. The company's latest EPS is USD -2.5897 and P/E is -0.17.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.63M | 0 | 0 | 0 | 0 |
Operating Income | -3.55M | -1.15M | -2.27M | -1.42M | -1.75M |
Net Income | -3.46M | -3.66M | -2.45M | -2.03M | -1.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 2.85M | 5.65M | 4.98M | 0 |
Operating Income | -10.84M | -11.9M | -22.66M | -22.18M | -11.31M |
Net Income | -10.13M | -19.55M | -17.9M | -18.64M | -13.42M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.15M | 4.32M | 2.03M | 1M | 534k |
Total Liabilities | 9.84M | 5.96M | 4.14M | 4.53M | 4.81M |
Total Equity | 3.31M | -1.64M | -2.1M | -3.52M | -4.28M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.8M | 29.13M | 22.84M | 19.08M | 2.03M |
Total Liabilities | 1.7M | 10.83M | 6.27M | 10.32M | 4.14M |
Total Equity | 1.1M | 18.3M | 16.57M | 8.77M | -2.1M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.56M | -4.63M | -10.3M | -784k | -2.26M |
Investing | -246k | 3.98M | 4.22M | N/A | 350k |
Financing | N/A | -440k | -550k | 475k | 1.63M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.52M | -10.16M | -14.73M | -13.25M | -10.3M |
Investing | 7M | -64k | -141k | -184k | 4.22M |
Financing | 1.41M | 34.05M | 8.43M | 2.91M | -550k |
Market Cap | 2.32M |
Price to Earnings Ratio | -0.17 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5.8 |
Price to Book Ratio | -1.11 |
Dividend Yield | - |
Shares Outstanding | 5.18M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0.64%) |
Company Name | Ritter Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.qualigeninc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions